The Global Hemostats Market is driven by factors such as the increasing number of surgeries, rising prevalence of chronic diseases, growing geriatric population, and increasing demand for advanced hemostatic products. The market is also expected to benefit from the growing demand for minimally invasive surgical procedures, as well as the increasing adoption of hemostats in ambulatory surgical centers. However, high costs associated with advanced hemostatic products and the risk of side effects associated with these products may hinder market growth to some extent. The market is also likely to face competition from alternative wound closure products such as sutures, staples, and adhesives. Despite these challenges, technological advancements and increasing R&D investments by key market players are expected to provide growth opportunities for the market in the coming years.
Key Competitors in the Hemostats Industry:
1. B.Braun Melsungen AG
B.Braun Melsungen AG, founded in 1839 and headquartered in Germany, is a leading manufacturer and supplier of medical devices and pharmaceutical products. The company operates in more than 60 countries worldwide and has a strong presence in Europe, North America, Asia, and Latin America. In March, 2022 B. Braun acquires Intermedt Medizin & Technik GmbH, a specialist in the preparation of dialysis concentrates
2. CareFusion Corporation
CareFusion Corporation, founded in 2009 and headquartered in California, USA, is a global medical technology company that specializes in the development and manufacture of medical devices and software solutions. The company operates in over 120 countries worldwide and has a strong presence in North America, Europe, and Asia.